NO312496B1 - Scopolamin-plaster - Google Patents
Scopolamin-plaster Download PDFInfo
- Publication number
- NO312496B1 NO312496B1 NO19971203A NO971203A NO312496B1 NO 312496 B1 NO312496 B1 NO 312496B1 NO 19971203 A NO19971203 A NO 19971203A NO 971203 A NO971203 A NO 971203A NO 312496 B1 NO312496 B1 NO 312496B1
- Authority
- NO
- Norway
- Prior art keywords
- active substance
- scopolamine
- therapeutic system
- base
- transdermal
- Prior art date
Links
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 title claims abstract description 37
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 title claims abstract description 37
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 title claims abstract description 37
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 title claims abstract description 37
- 229960002646 scopolamine Drugs 0.000 title claims abstract description 37
- 239000013543 active substance Substances 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 12
- 238000009472 formulation Methods 0.000 claims abstract description 10
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims abstract description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920005601 base polymer Polymers 0.000 claims abstract description 4
- 239000000853 adhesive Substances 0.000 claims description 25
- 239000012528 membrane Substances 0.000 claims description 18
- 239000010410 layer Substances 0.000 claims description 15
- 239000011888 foil Substances 0.000 claims description 14
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 8
- 239000011505 plaster Substances 0.000 claims description 8
- 239000012790 adhesive layer Substances 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 6
- 230000001681 protective effect Effects 0.000 claims description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- BODMYPYTCKYRSP-UHFFFAOYSA-N 1,1-dioctylcyclohexane Chemical compound CCCCCCCCC1(CCCCCCCC)CCCCC1 BODMYPYTCKYRSP-UHFFFAOYSA-N 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- 150000002191 fatty alcohols Chemical class 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 150000002430 hydrocarbons Chemical class 0.000 claims description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims 1
- 229940055577 oleyl alcohol Drugs 0.000 claims 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 description 22
- 229920000058 polyacrylate Polymers 0.000 description 15
- 239000000126 substance Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 229920000728 polyester Polymers 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000007788 liquid Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- XBIUWALDKXACEA-UHFFFAOYSA-N 3-[bis(2,4-dioxopentan-3-yl)alumanyl]pentane-2,4-dione Chemical compound CC(=O)C(C(C)=O)[Al](C(C(C)=O)C(C)=O)C(C(C)=O)C(C)=O XBIUWALDKXACEA-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- 229940100640 transdermal system Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- -1 polyethylene terephthalate Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Fats And Perfumes (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4433004 | 1994-09-16 | ||
| DE4438989A DE4438989C2 (de) | 1994-09-16 | 1994-10-31 | Scopolaminpflaster |
| PCT/EP1995/003555 WO1996008251A1 (de) | 1994-09-16 | 1995-09-09 | Scopolaminpflaster |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971203D0 NO971203D0 (no) | 1997-03-14 |
| NO971203L NO971203L (no) | 1997-03-14 |
| NO312496B1 true NO312496B1 (no) | 2002-05-21 |
Family
ID=25940173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19971203A NO312496B1 (no) | 1994-09-16 | 1997-03-14 | Scopolamin-plaster |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5714162A (sv) |
| EP (1) | EP0781134B9 (sv) |
| JP (1) | JP4466977B2 (sv) |
| CN (1) | CN1087938C (sv) |
| AT (1) | ATE262333T1 (sv) |
| AU (1) | AU695698B2 (sv) |
| CA (1) | CA2200189C (sv) |
| CZ (1) | CZ289313B6 (sv) |
| DE (1) | DE59510883D1 (sv) |
| ES (1) | ES2219665T3 (sv) |
| FI (1) | FI118885B (sv) |
| HU (1) | HUT77383A (sv) |
| IL (1) | IL115189A (sv) |
| MX (1) | MX9701968A (sv) |
| MY (1) | MY112477A (sv) |
| NO (1) | NO312496B1 (sv) |
| NZ (1) | NZ292921A (sv) |
| PL (1) | PL182158B1 (sv) |
| SK (1) | SK282640B6 (sv) |
| WO (1) | WO1996008251A1 (sv) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19738643C2 (de) * | 1997-09-04 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung |
| US6087341A (en) * | 1998-02-12 | 2000-07-11 | The Board Of Trustees Of The Leland Standford Junior University | Introduction of nucleic acid into skin cells by topical application |
| US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
| US20050208117A1 (en) * | 2001-03-16 | 2005-09-22 | Venkatraman Subramanian S | Transdermal administration of fentanyl and analogs thereof |
| CZ307857B6 (cs) * | 2001-03-16 | 2019-07-03 | Alza Corporation | Transdermální náplast pro podávání fentanylu nebo jeho analogu |
| DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| DK1613297T3 (da) * | 2003-04-14 | 2007-09-24 | Lohmann Therapie Syst Lts | Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin |
| EP1620112A4 (en) * | 2003-04-17 | 2007-04-25 | Univ Columbia | DESMOGLEIN 4 IS A NEW GENUS INVOLVED IN HAIR GROWTH |
| CA2557532A1 (en) * | 2004-04-23 | 2005-11-10 | Angela M. Christiano | Inhibition of hairless protein mrna |
| FR2884143B1 (fr) * | 2005-04-08 | 2007-06-22 | Millet Innovation Sa | Timbre dermique rechargeable |
| US20070010550A1 (en) * | 2005-07-08 | 2007-01-11 | The Board Of Regents Of The University Of Texas | Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia |
| CA2643037C (en) * | 2006-02-27 | 2014-08-05 | Noven Pharmaceuticals, Inc. | Compositions and methods for delivery of amino-functional drugs |
| DE102006028987A1 (de) * | 2006-06-24 | 2007-12-27 | Lts Lohmann Therapie-Systeme Ag | Ultraschallverstärktes transdermales therapeutisches System |
| RU2499583C2 (ru) * | 2007-10-15 | 2013-11-27 | Алза Корпорейшн | Заместительное трансдермальное введение фентанила один раз в день |
| CN102764342B (zh) * | 2012-07-17 | 2013-12-04 | 陈鼎汉 | 治疗褥疮、糖尿病伤口、烫伤的药膏 |
| EP3943156A4 (en) * | 2019-03-19 | 2023-01-04 | Nobelpharma Co., Ltd. | MEDICAL COMPOSITION WITH EXCELLENT ABSORPTION OF ACTIVE SUBSTANCES INTO THE LIVING BODY AND EXCELLENT CHEMICAL STABILITY |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8104929A (nl) * | 1980-11-12 | 1982-06-01 | Alza Corp | Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan. |
| US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
| US4832953A (en) * | 1987-08-13 | 1989-05-23 | Alza Corporation | Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix |
| US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| ATE101511T1 (de) * | 1988-08-02 | 1994-03-15 | Ciba Geigy Ag | Mehrschichtiges pflaster. |
| DE3908431A1 (de) * | 1989-03-15 | 1990-09-27 | Lohmann Therapie Syst Lts | Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung |
| US5176917A (en) * | 1989-03-15 | 1993-01-05 | Lts Lohmann | Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances |
| JPH04261119A (ja) * | 1991-02-13 | 1992-09-17 | Lintec Corp | 経皮吸収型貼付剤 |
-
1995
- 1995-01-05 US US08/369,019 patent/US5714162A/en not_active Expired - Lifetime
- 1995-09-06 IL IL11518995A patent/IL115189A/xx not_active IP Right Cessation
- 1995-09-06 MY MYPI95002638A patent/MY112477A/en unknown
- 1995-09-09 HU HU9701966A patent/HUT77383A/hu not_active Application Discontinuation
- 1995-09-09 WO PCT/EP1995/003555 patent/WO1996008251A1/de active IP Right Grant
- 1995-09-09 ES ES95932020T patent/ES2219665T3/es not_active Expired - Lifetime
- 1995-09-09 DE DE59510883T patent/DE59510883D1/de not_active Expired - Lifetime
- 1995-09-09 MX MX9701968A patent/MX9701968A/es not_active IP Right Cessation
- 1995-09-09 AT AT95932020T patent/ATE262333T1/de not_active IP Right Cessation
- 1995-09-09 PL PL95319259A patent/PL182158B1/pl not_active IP Right Cessation
- 1995-09-09 JP JP50989096A patent/JP4466977B2/ja not_active Expired - Lifetime
- 1995-09-09 SK SK338-97A patent/SK282640B6/sk unknown
- 1995-09-09 CA CA002200189A patent/CA2200189C/en not_active Expired - Fee Related
- 1995-09-09 AU AU35231/95A patent/AU695698B2/en not_active Ceased
- 1995-09-09 CN CN95195097A patent/CN1087938C/zh not_active Expired - Fee Related
- 1995-09-09 CZ CZ1997757A patent/CZ289313B6/cs not_active IP Right Cessation
- 1995-09-09 EP EP95932020A patent/EP0781134B9/de not_active Expired - Lifetime
- 1995-09-09 NZ NZ292921A patent/NZ292921A/en not_active IP Right Cessation
-
1997
- 1997-03-14 NO NO19971203A patent/NO312496B1/no unknown
- 1997-03-14 FI FI971097A patent/FI118885B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL319259A1 (en) | 1997-08-04 |
| CZ75797A3 (en) | 1997-07-16 |
| JPH10505825A (ja) | 1998-06-09 |
| NO971203D0 (no) | 1997-03-14 |
| EP0781134B1 (de) | 2004-03-24 |
| NO971203L (no) | 1997-03-14 |
| SK33897A3 (en) | 1997-09-10 |
| CA2200189A1 (en) | 1996-03-21 |
| MY112477A (en) | 2001-06-30 |
| WO1996008251A1 (de) | 1996-03-21 |
| IL115189A (en) | 1999-12-22 |
| AU695698B2 (en) | 1998-08-20 |
| EP0781134B9 (de) | 2004-09-29 |
| NZ292921A (en) | 1998-09-24 |
| CN1158084A (zh) | 1997-08-27 |
| US5714162A (en) | 1998-02-03 |
| CA2200189C (en) | 2008-06-17 |
| FI971097A0 (sv) | 1997-03-14 |
| ES2219665T3 (es) | 2004-12-01 |
| MX9701968A (es) | 1998-02-28 |
| ATE262333T1 (de) | 2004-04-15 |
| AU3523195A (en) | 1996-03-29 |
| JP4466977B2 (ja) | 2010-05-26 |
| CN1087938C (zh) | 2002-07-24 |
| CZ289313B6 (cs) | 2001-12-12 |
| SK282640B6 (sk) | 2002-10-08 |
| FI971097A (sv) | 1997-03-14 |
| PL182158B1 (pl) | 2001-11-30 |
| HUT77383A (hu) | 1998-04-28 |
| IL115189A0 (en) | 1995-12-31 |
| EP0781134A1 (de) | 1997-07-02 |
| FI118885B (sv) | 2008-04-30 |
| DE59510883D1 (de) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10709669B2 (en) | Microreservoir system based on polysiloxanes and ambiphilic solvents | |
| AU678237B2 (en) | Active substance-containing plaster | |
| US5306503A (en) | Patch with a high content of softening ingredients | |
| NO312496B1 (no) | Scopolamin-plaster | |
| KR101080026B1 (ko) | 의료용 경피 흡수 테이프 제제용 비수성 점착제 및 의료용경피 흡수 테이프 제제 및 그 제조법 | |
| US20040057985A1 (en) | Transdermal therapeutic system comprising the active ingredient oxybutynin | |
| TWI388346B (zh) | 黏著性材料及黏著性製劑 | |
| CN102258501A (zh) | 含有芬太尼或其相关物质的透皮治疗体系 | |
| DK175774B1 (da) | Farmaceutisk præparat til transdermal systemisk administration af et farmakologisk aktivt middel, fremgangsmåde til fremstilling deraf samt anvendelse af ketotifen til fremstilling af et lægemiddel | |
| KR100473677B1 (ko) | 물리적 특성이 향상된 폴리아크릴레이트 매트릭스를 구비한 경피 또는 국소 플래스터 시스템 | |
| WO2004032927A1 (en) | Transdermal preparations comprising eperisone, tolperisone or salts thereof | |
| JP3014188B2 (ja) | アクリル系ゲル材およびアクリル系ゲル製剤 | |
| JP2003534365A (ja) | 非吸蔵性裏打ち層を有する吸蔵性経皮治療系 | |
| JP4331984B2 (ja) | 医療用経皮吸収テープ製剤用水性エマルジョン粘着剤並びに医療用経皮吸収テープ製剤及びその製造法 | |
| WO2004084946A1 (ja) | 経皮吸収用粘着剤、経皮吸収用粘着剤組成物及び経皮吸収製剤 | |
| JP2971998B2 (ja) | アクリル系粘着シートおよびこれを用いてなる粘着製剤 | |
| KR100394830B1 (ko) | 스코폴아민패치 | |
| JPS63307814A (ja) | 疾患治療用貼付剤 | |
| JP3450864B2 (ja) | 経皮吸収製剤 | |
| JP4617069B2 (ja) | 貼付剤 | |
| DK175981B1 (da) | Farmaceutisk præparat til transdermal systemisk administration af et farmakologisk aktivt middel, indeholdende tizanidin samt fremgangsmåde til fremstilling af præparatet | |
| JPH1176392A (ja) | 貼付剤 | |
| JPH05294832A (ja) | 経皮吸収貼付剤 | |
| JPH06157297A (ja) | 医薬部材 |